Canonical ingredient
Pregna-1,4-diene-3,20-dione, 9-chloro-11-hydroxy-16-methyl- 17,21-bis(1-oxopropoxy)-, (11ß,16ß)-
BECLOMETHASONE DIPROPIONATE
35 linked products
Official identifiers
CAS 5534-09-8ChEBI CHEBI:3002InChI InChI=1S/C28H37ClO7/c1-6-23(33)35-15-22(32)28(36-24(34)7-2)16(3)12-20-19-9-8-17-13-18(30)10-11-25(17,4)27(19,29)21(31)14-26(20,28)5/h10-11,13,16,19-21,31H,6-9,12,14-15H2,1-5H3/t16-,19-,20-,21-,25-,26-,27-,28-/m0/s1InChIKey KUVIULQEHSCUHY-XYWKZLDCSA-NKEGG_COMPOUND C07813SMILES [H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@@]21C
Names and synonyms
- Pregna-1,4-diene-3,20-dione, 9-chloro-11-hydroxy-16-methyl- 17,21-bis(1-oxopropoxy)-, (11ß,16ß)- (en)
- beclomethasone dipropionate (en)
- Dipropionate de béclométhasone (fr)
- (11?,16?)-9-chloro-11-hydroxy-16-méthyl-17,21-bis(1-oxopropoxy)-pregna-1,4-diène-3,20-dione (fr-CA)
Source-scoped chemical properties
Every value keeps its own authority, licence and retrieval date. Conflicting values are not silently merged.
- canada dsl listing
- listed
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl bioaccumulative
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl inherently toxic aquatic
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl meets cepa categorization
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl meets environmental
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl meets human health
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl persistent
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl substance category
- Organics
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
Safety and technical documents
General references and manufacturer-specific SDS documents are kept separate.
No verified SDS or technical sheet is linked yet. This absence is explicit and does not mean that no document exists.
End-to-end traceability
Only links supported by an identified source are published. Missing evidence remains explicitly unknown.
Evidence still missing
- Country or region of origin
- Raw-material producer
- Ingredient manufacturer
- Distributor
- Transformation steps
Documented origins
No origin has been proven yet by an explicit source.
Documented organizations
No organization has been proven yet by an explicit source.
Documented transformations
No transformation step has been proven yet by an explicit source.
Method: a company’s registration country is never used as evidence of a material’s origin.
Products containing this ingredient
ALTI-BECLOMETHASONE DIPROPIONATE INHALER 50MCG/MD
50 · MCG · ACT
APO-BECLOMETHASONE NASAL SPRAY
50 · MCG · ACT
BECLODISK - PWR INH 100MCG/BLISTER
100 · MCG · BLISTER
BECLODISK - PWR INH 200MCG/BLISTER
200 · MCG · BLISTER
BECLODISK PWR 100MCG/BLISTER
100 · MCG · BLISTER
BECLODISK PWR 200MCG/BLISTER
200 · MCG · BLISTER
BECLOFORTE 250MCG/AEM
250 · MCG · ACT
BECLOFORTE INHALER - AEM INH 250MCG/AEM
250 · MCG · ACT
BECLOMETHASONE AQUEOUS NASAL SPRAY 50MCG/METERED DOSE
50 · MCG · ACT
BECLOMETHASONE DIPROPIONATE NAS-SPR 50MCG/AEM
50 · MCG · ACT
BECLOMETHASONE DIPROPIONATE NASAL INHALER
50 · MCG · ACT
BECLOMETHASONE DIPROPIONATE ORAL INHALER
50 · MCG · ACT
BECLOMETHASONE NASAL SPRAY
50 · MCG · ACT
BECLOVENT - AEM 50MCG/AEM
50 · MCG · ACT
BECLOVENT AEM 50MCG/AEM
50 · MCG · ACT
BECLOVENT ROTACAPS - INH 100MCG/CAPSULE
100 · MCG · CAP
BECLOVENT ROTACAPS - INH 200MCG/CAP
200 · MCG · CAP
BECLOVENT ROTACAPS 100MCG
100 · MCG · CAP
BECLOVENT ROTACAPS 200MCG
200 · MCG · CAP
BECONASE AQ NASAL AEM 50MCG/AEM
50 · MCG · ACT
BECONASE NASAL AEM 50MCG/AEM
50 · MCG · ACT
MYLAN-BECLO AQ
50 · MCG · ACT
PROPADERM
0.025 · % · W/W
PROPADERM CREAM 0.025%
.025 · % · %
PROPADERM LOT 0.025%
.025 · % · %
PROPADERM LOTION 0.025%
0.025 · %
QNASL
40 · MCG · ACT
QNASL
80 · MCG · ACT
QVAR
50 · MCG · ACT
QVAR
100 · MCG · ACT
RATIO-BECLOMETHASONE AQ
50 · MCG · ACT
RIVANASE AQ.NASAL SPRAY 50MCG/METERED DOSE
50 · MCG · ACT
TRIMBOW
100 · MCG · ACT
VANCENASE AER 50MCG
50 · MCG · ACT
VANCERIL AEM 50MCG
50 · MCG · ACT